Literature DB >> 27631148

Probable Posttraumatic Stress Disorder in the US Veteran Population According to DSM-5: Results From the National Health and Resilience in Veterans Study.

Blair E Wisco1,2, Brian P Marx3, Mark W Miller3, Erika J Wolf3, Natalie P Mota4, John H Krystal4, Steven M Southwick4, Robert H Pietrzak4.   

Abstract

OBJECTIVE: With the publication of DSM-5, important changes were made to the diagnostic criteria for posttraumatic stress disorder (PTSD), including the addition of 3 new symptoms. Some have argued that these changes will further increase the already high rates of comorbidity between PTSD and other psychiatric disorders. This study examined the prevalence of DSM-5 PTSD, conditional probability of PTSD given certain trauma exposures, endorsement of specific PTSD symptoms, and psychiatric comorbidities in the US veteran population.
METHODS: Data were analyzed from the National Health and Resilience in Veterans Study (NHRVS), a Web-based survey of a cross-sectional, nationally representative, population-based sample of 1,484 US veterans, which was fielded from September through October 2013. Probable PTSD was assessed using the PTSD Checklist-5.
RESULTS: The weighted lifetime and past-month prevalence of probable DSM-5 PTSD was 8.1% (SE = 0.7%) and 4.7% (SE = 0.6%), respectively. Conditional probability of lifetime probable PTSD ranged from 10.1% (sudden death of close family member or friend) to 28.0% (childhood sexual abuse). The DSM-5 PTSD symptoms with the lowest prevalence among veterans with probable PTSD were trauma-related amnesia and reckless and self-destructive behavior. Probable PTSD was associated with increased odds of mood and anxiety disorders (OR = 7.6-62.8, P < .001), substance use disorders (OR = 3.9-4.5, P < .001), and suicidal behaviors (OR = 6.7-15.1, P < .001).
CONCLUSIONS: In US veterans, the prevalence of DSM-5 probable PTSD, conditional probability of probable PTSD, and odds of psychiatric comorbidity were similar to prior findings with DSM-IV-based measures; we found no evidence that changes in DSM-5 increase psychiatric comorbidity. Results underscore the high rates of exposure to both military and nonmilitary trauma and the high public health burden of DSM-5 PTSD and comorbid conditions in veterans. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27631148     DOI: 10.4088/JCP.15m10188

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  18 in total

1.  Evaluation of the effect of doxasozin and zonisamide on voluntary ethanol intake in mice that experienced chronic intermittent ethanol exposure and stress.

Authors:  Marcelo F Lopez; Sarah E Reasons; Benjamin A Carper; Tracy L Nolen; Rick L Williams; Howard C Becker
Journal:  Alcohol       Date:  2020-07-24       Impact factor: 2.405

Review 2.  The National Health and Resilience in Veterans Study: A Narrative Review and Future Directions.

Authors:  Brienna M Fogle; Jack Tsai; Natalie Mota; Ilan Harpaz-Rotem; John H Krystal; Steven M Southwick; Robert H Pietrzak
Journal:  Front Psychiatry       Date:  2020-12-09       Impact factor: 4.157

3.  Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder.

Authors:  Elina A Stefanovics; Robert A Rosenheck; Karen M Jones; Grant Huang; John H Krystal
Journal:  Psychiatr Q       Date:  2018-03

4.  Dimensionality of DSM-5 posttraumatic stress disorder and its association with suicide attempts: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Chiung M Chen; Young-Hee Yoon; Thomas C Harford; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-04-11       Impact factor: 4.328

5.  Oxytocin receptor gene polymorphisms, attachment, and PTSD: Results from the National Health and Resilience in Veterans Study.

Authors:  Lauren M Sippel; Shizhong Han; Laura E Watkins; Ilan Harpaz-Rotem; Steven M Southwick; John H Krystal; Miranda Olff; Richard Sherva; Lindsay A Farrer; Henry R Kranzler; Joel Gelernter; Robert H Pietrzak
Journal:  J Psychiatr Res       Date:  2017-07-08       Impact factor: 4.791

6.  Genomics of posttraumatic stress disorder in veterans: Methods and rationale for Veterans Affairs Cooperative Study #575B.

Authors:  Krishnan Radhakrishnan; Mihaela Aslan; Kelly M Harrington; Robert H Pietrzak; Grant Huang; Sumitra Muralidhar; Kelly Cho; Rachel Quaden; David Gagnon; Saiju Pyarajan; Ning Sun; Hongyu Zhao; Michael Gaziano; John Concato; Murray B Stein; Joel Gelernter
Journal:  Int J Methods Psychiatr Res       Date:  2019-02-14       Impact factor: 4.035

Review 7.  Posttraumatic Stress Disorder in Older Adults: A Conceptual Review.

Authors:  Anica Pless Kaiser; Joan M Cook; Debra M Glick; Jennifer Moye
Journal:  Clin Gerontol       Date:  2018-11-13       Impact factor: 2.619

8.  Propranolol produces short-term facilitation of extinction in a rabbit model of post-traumatic stress disorder.

Authors:  Lauren B Burhans; Carrie A Smith-Bell; Bernard G Schreurs
Journal:  Neuropharmacology       Date:  2018-03-23       Impact factor: 5.250

9.  Symptom structure of PTSD and co-morbid depressive symptoms - a network analysis of combat veteran patients.

Authors:  Amit Lazarov; Benjamin Suarez-Jimenez; Ofir Levi; Daniel D L Coppersmith; Gadi Lubin; Daniel S Pine; Yair Bar-Haim; Rany Abend; Yuval Neria
Journal:  Psychol Med       Date:  2019-08-27       Impact factor: 7.723

10.  The Dissociative Subtype of PTSD Scale: Initial Evaluation in a National Sample of Trauma-Exposed Veterans.

Authors:  Erika J Wolf; Karen S Mitchell; Naomi Sadeh; Christina Hein; Isaac Fuhrman; Robert H Pietrzak; Mark W Miller
Journal:  Assessment       Date:  2015-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.